Journal
EMBO REPORTS
Volume 21, Issue 3, Pages -Publisher
WILEY
DOI: 10.15252/embr.201948328
Keywords
acetylation; acetyltransferase; anti-apoptosis; Tau; beta-catenin
Categories
Funding
- Ministry of Science and Technology of China [2016YFC1305800]
- Natural Science Foundation of China [91632305, 91632111, 31730035, 81721005, 91949205, 31171028]
- Guangdong Provincial Key ST Program [2018B030336001]
- China Human Brain Bank Consortium
Ask authors/readers for more resources
Overexpressing Tau counteracts apoptosis and increases dephosphorylated beta-catenin levels, but the underlying mechanisms are elusive. Here, we show that Tau can directly and robustly acetylate beta-catenin at K49 in a concentration-, time-, and pH-dependent manner. beta-catenin K49 acetylation inhibits its phosphorylation and its ubiquitination-associated proteolysis, thus increasing beta-catenin protein levels. K49 acetylation further promotes nuclear translocation and the transcriptional activity of beta-catenin, and increases the expression of survival-promoting genes (bcl2 and survivin), counteracting apoptosis. Mutation of Tau's acetyltransferase domain or co-expressing non-acetylatable beta-catenin-K49R prevents increased beta-catenin signaling and abolishes the anti-apoptotic function of Tau. Our data reveal that Tau preserves beta-catenin by acetylating K49, and upregulated beta-catenin/survival signaling in turn mediates the anti-apoptotic effect of Tau.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available